| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2724186 | Journal of Pain and Symptom Management | 2014 | 5 Pages |
Abstract
Octreotide, a synthetic analogue of the hormone somatostatin, is primarily used in palliative medicine because of its antisecretory effect and has been shown to be effective in the management of bowel obstruction, nausea, and diarrhea. Octreotide also has been successfully used for the management of bronchorrhea in both inpatient and outpatient settings. We report the case of a 47-year-old female with a history of bronchioloalveolar cell carcinoma whose copious bronchial secretions were controlled with octreotide. Octreotide should be further evaluated as a first-line treatment for bronchorrhea.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Meera Pahuja, Ray W. Shepherd, Laurel J. Lyckholm,